Hoever Michael, Zbinden Peter
Discovery Partners International AG, Gewerbestrasse 16, CH-4123 Allschwil, Switzerland.
Drug Discov Today. 2004 Apr 15;9(8):358-65. doi: 10.1016/S1359-6446(04)03037-5.
This review describes recent developments in the evolutionary process of microarrayed compound screening (microARCS to become a robust and efficient ultra-high-throughput screening technology. Improvements in compound spotting (including new quality-control methods), gel casting and imaging, together with software capable of automatic analysis and deconvolution of images, have helped to streamline the screening process. A variety of screening projects using cell-based and non-cell-based approaches have been successfully concluded using microARCS. Comparison of hits derived from standard microtitre-plate-based screening and from microARCS reveals excellent overlap. Furthermore, there seems to be no bias towards finding compounds within a particular range of logP values, even though compounds are solubilized from a dry state during the course of the assay.